ID
33048
Beschreibung
This form contains a form to document the randomisation number, investigational products and the pharmacokinetics. To be assessed at the visits V1-3. Study ID: 103629 Clinical Study ID: TRX103629 Study Title: An open-label, randomized, 3-period crossover study to evaluate sumatriptan and naproxen pharmacokinetics for a combination tablet product containing sumatriptan/naproxen sodium followed by IMITREX™ (sumatriptan succinate) Injection 4mg administered using the IMITREX STATdose System and a sumatriptan/naproxen sodium tablet followed by IMITREX (sumatriptan succinate) Injection 6mg administered using the STATdose system compared with an IMITREX tablet 100mg followed by an IMITREX tablet 100mg Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00875784 Clinicaltrials.gov link: https://clinicaltrials.gov/ct2/show/NCT00875784 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders
Link
https://clinicaltrials.gov/ct2/show/NCT00875784
Stichworte
Versionen (3)
- 18.11.18 18.11.18 -
- 25.11.18 25.11.18 -
- 25.11.18 25.11.18 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
25. November 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Sumatriptan pharmacokinetics for TREXIMA/IMITREX NCT00875784
Randomisation Number, Investigational Products, Pharmacokinetics Blood
Beschreibung
Randomisation Number (Only Visit 1)
Alias
- UMLS CUI-1
- C1300638
- UMLS CUI-2
- C0034656
Beschreibung
Subject's randomisation
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0034656
Beschreibung
Randomisation number
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1300638
- UMLS CUI [1,2]
- C0034656
Beschreibung
Date of randomisation
Datentyp
date
Alias
- UMLS CUI [1]
- C0034656
Beschreibung
Investigational Product
Alias
- UMLS CUI-1
- C0304229
Beschreibung
Treatment Confirmation
Alias
- UMLS CUI-1
- C0750484
- UMLS CUI-2
- C0087111
Beschreibung
Receivement of the correct treatment
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0750484
- UMLS CUI [1,2]
- C0087111
Beschreibung
Reason(s) in case the subject did not receive the correct treatment
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C3827420
- UMLS CUI [1,3]
- C0392360
Beschreibung
Dosing Date and Time
Alias
- UMLS CUI-1
- C0178602
- UMLS CUI-2
- C1264639
Beschreibung
Pharmacokinetics Blood
Alias
- UMLS CUI-1
- C0031328
- UMLS CUI-2
- C0005767
Beschreibung
Planned relative time of blood sample collection for pharmacokinetics analysis
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Beschreibung
To be assessed for all timepoints up to 4 hours post-dose (included)
Datentyp
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Beschreibung
To be assessed for all timepoints from 6 hours post-dose on (included).
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C1264639
- UMLS CUI [1,2]
- C0031328
- UMLS CUI [1,3]
- C0005834
Ähnliche Modelle
Randomisation Number, Investigational Products, Pharmacokinetics Blood
C0034656 (UMLS CUI-2)
C0034656 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,2])
C0087111 (UMLS CUI-2)
C0087111 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])
C0005767 (UMLS CUI-2)
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])